Urinary Catheters Market Size & Outlook, 2026-2034

Urinary Catheters Market Overview

The global urinary catheters market size is valued at USD 6.54 billion in 2025 and is estimated to reach USD 11.60 billion by 2034, growing at a CAGR of 6.6% during the forecast period. The growth of the market is attributed to the rising prevalence of urological disorders such as urinary incontinence, benign prostatic hyperplasia (BPH), and spinal cord injuries, which necessitate long-term catheterization.

Key Trends and Insights

• North America dominated the urinary catheters market with the largest revenue share of 34.97% in 2025.
• The Asia Pacific urinary catheters industry is experiencing the fastest CAGR of 7.27% 
• The urinary catheters market in the U.S. accounted for the largest market revenue share of 82.27% in North America in 2025.
• Based on product, the intermittent catheters segment led the market with the largest revenue share of 57.91% in 2025.
• Based on application, the urinary incontinence segment led the market with the largest revenue share of 37.29% in 2025.
• Based on type, the coated catheters segment led the market with the largest revenue share of 61.06% in 2025

Market Revenue Figures

• 2025 Market Size: USD 6.54 billion
• 2034 Projected Market Size: USD 11.60 billion
• CAGR (2026-2034): 6.6%
• Dominating Region: North America
• Fastest-Growing Region: Asia Pacific

The growing ageing population and increasing number of surgical procedures and hospitalisations further fuel product demand. In addition, the expanding adoption of home healthcare and the rising preference for minimally invasive and non-invasive urinary management solutions, such as external and intermittent catheters, are accelerating market growth. Technological advancements, including antimicrobial coatings and silicone-based materials that enhance patient comfort and reduce infection risk, along with increased awareness among patients and caregivers about urinary management options, are expected to further support the market's expansion over the forecast period.

Latest Market Trends

Accelerating shift toward Coated and Infection-Resistant Catheters

Catheter-associated urinary tract infections remain a major clinical challenge worldwide, and hospitals are adopting coated catheters to reduce the rate of infection, improve patient outcomes, and comply with infection control standards. Manufacturers are investing in advanced materials and surface treatment technologies to enhance the biocompatibility, lubrication, and durability of catheters. Hence, coated catheters are capturing a larger market share and demonstrating faster growth than uncoated variants.

Technological Innovation and the Rise of Smart Catheter Systems

Manufacturers are exploring sensor-embedded catheters that can monitor urine output, detect temperature changes, or identify early signs of infection. The need for real-time patient monitoring in ICUs and post-operative care drives such smart technological integration. Since it is still in early stages, these technologies represent a transformative shift towards digital health integration in urology products.

To get more insights about this report Download Free Sample Report

Market Drivers

Rising Prevalence of Urological Disorders

Conditions such as urinary incontinence, overactive bladder, benign prostatic hyperplasia, spinal cord injuries, multiple sclerosis and post-operative urinary retention are becoming more common due to ageing populations, sedentary lifestyles and increased survival of chronic disease patients. These conditions often require the use of temporary or long-term catheters, directly boosting demand. With urinary incontinence affecting millions globally, especially older adults and women, the need for reliable catheterisation solutions is expanding rapidly across hospitals, long-term care facilities and home care settings.

Rapidly ageing global population

A rapidly ageing global population is more vulnerable to urinary complications and chronic illnesses that require catheterisation. Individuals aged 65 and above are experiencing higher rates of prostate enlargement, mobility impairment, bladder dysfunction and neurological conditions. As life expectancy increases, the share of geriatric patients needing urinary management solutions grows substantially. Healthcare systems worldwide are reporting rising catheter utilisation in elderly care, ICU settings and post-surgical recovery units.

Market Restraint

High Risk of Catheter-Associated Urinary Tract Infections (CAUTIs)

Catheterisation remains one of the leading causes of hospital-acquired infections worldwide, especially in long-term care facilities and ICUs. These infections increase patient morbidity, prolong hospital stays and raise treatment costs. Many hospitals attempt to reduce catheter use or shorten catheter duration due to concerns about infections, which directly limits market expansion for long-term catheters. Although coated catheters are helping minimise infection risks, CAUTIs still pose a major clinical and regulatory challenge, particularly in regions with strict healthcare guidelines.

Market Opportunity

Rapid Expansion of Home Healthcare & Self-Catheterisation

As more patients transition from hospital-based care to home-based management of chronic conditions, the demand for convenient, sterile, single-use, and user-friendly catheters is increasing. Intermittent and external catheters designed for self-use are seeing a strong rise among individuals with spinal cord injuries, neurogenic bladder disorders and chronic urinary retention. Governments and insurance providers in many countries are expanding reimbursement policies for home care devices, creating long-term opportunities for manufacturers offering portable, pre-lubricated and easy-to-handle products. This also opens the door for companies to develop training tools, subscription-based catheter supply models, and personalised home-care kits, further expanding recurring revenue streams.

Regional Analysis

The North America urinary catheters industry dominated with the largest revenue share of 34.97% in 2025, driven by a combination of demographic, clinical, and technological factors. A key driver is the rising prevalence of urological conditions such as urinary incontinence, benign prostatic hyperplasia (BPH), and bladder dysfunction, particularly among the ageing population. According to the U.S. Census Bureau, the number of individuals aged 65 and older is increasing rapidly, fueling demand for long-term catheterisation and specialised urological care. The region's well-established healthcare infrastructure, strong reimbursement systems, and efficient distribution networks ensure broad accessibility of urinary catheters across hospitals, nursing homes, and home healthcare settings.

The U.S. urinary catheter industry is primarily driven by technological advancements, changing patient preferences, and evolving healthcare practices. There is a growing shift toward intermittent and external catheters, which are perceived as safer, more comfortable, and suitable for home care settings. Innovations such as antimicrobial coatings, hydrophilic surfaces, and drug-eluting catheters enhance patient safety by reducing infection risks and improving usability.

Asia Pacific Market Insights

The Asia Pacific urinary catheters industry is expected to experience the fastest CAGR of 7.27% during the forecast period, fueled by a combination of demographic and clinical factors, including a rapidly ageing population, the rising prevalence of chronic diseases such as diabetes and neurological disorders, and an increasing burden of urological cancers. Countries like Japan, China, and South Korea are experiencing significant growth in their elderly populations, leading to higher incidences of urinary incontinence and bladder dysfunction. The growing prevalence of prostate, bladder, and kidney cancers in the region also necessitates catheterisation during post-operative care, collectively accelerating market growth.

The urinary catheter industry in China is witnessing significant growth, driven by an ageing population, rising prevalence of urological disorders, and increasing awareness of advanced urinary management solutions. The growing number of elderly individuals is leading to higher rates of urinary incontinence, benign prostatic hyperplasia (BPH), and bladder dysfunction, fueling demand for both intermittent and long-term catheterisation.

Europe Market Insights

The Europe urinary catheters industry is witnessing steady growth, driven by a combination of demographic, clinical, and policy-related factors. A key contributor is the region's ageing population, which is leading to an increased prevalence of age-related urological conditions, including urinary incontinence, benign prostatic hyperplasia (BPH), and prostate cancer. Additionally, the rising incidence of chronic diseases such as diabetes, along with neurological disorders like multiple sclerosis and spinal cord injuries, is driving higher demand for long-term catheterisation. 

The UK is evolving with a focus on patient-centric care, technological innovation, and the adoption of home healthcare. There is an increasing preference for intermittent and external catheters, driven by their safety, comfort, and suitability for self-catheterisation at home. Technological advancements, including antimicrobial coatings, hydrophilic materials, and drug-eluting catheters, are helping reduce infection risks and enhance patient outcomes.

Latin America Market Insights

Latin America is primarily driven by the rising prevalence of chronic diseases such as diabetes, stroke, and spinal cord injuries, all of which contribute to urinary complications requiring catheterisation. The region is witnessing a demographic shift with a growing elderly population, particularly in countries such as Brazil and Argentina, where age-related urological conditions such as benign prostatic hyperplasia and incontinence are becoming more common. The increasing number of surgical procedures, particularly in urology, gynaecology, and orthopaedics, further boosts short-term demand for catheters in perioperative care.

Brazil dominates the Latin American urinary catheters market due to its large patient population, rising prevalence of urological disorders and expanding access to public healthcare programs through SUS. The country also has a rapidly growing elderly demographic, which increases demand for long-term catheterisation products.

Middle East and Africa Market Insights

The Middle East and Africa (MEA) is witnessing steady growth, driven by rising disease prevalence, demographic shifts, and expanding healthcare infrastructure. A significant increase in chronic conditions such as diabetes, prostate cancer, urinary incontinence, and spinal cord injuries is fueling the need for catheter-based urological care. The region's ageing population, particularly in GCC countries and South Africa, further contributes to the demand for long-term and intermittent catheterisation.

Saudi Arabia holds the top position in the MEA urinary catheters market due to its well-developed healthcare infrastructure and high healthcare spending, driven by VISION 2030. The country has a significant burden of diabetes, obesity and chronic kidney disease, all of which contribute to rising urinary complications requiring catheterisation.

Product Insights

The intermittent catheters segment held the largest share in 2025. The growth is attributed to a greater preference for silicone implants owing to their widespread adoption across hospitals, long-term care facilities, and home healthcare settings. Intermittent catheters are preferred for their reduced risk of urinary tract infections, ease of use, and suitability for self-catheterisation, which empowers patients to manage their condition independently.

The external catheters segment is expected to witness significant growth over the forecast period, driven by increasing demand for non-invasive and comfortable urinary management solutions. External catheters, including condom catheters and female external devices, are favoured in home care and outpatient settings due to their ease of application and lower risk of infection compared to indwelling catheters.

Application Insights

The urinary incontinence segment registered the largest share in 2025. The growth is due to the high prevalence of incontinence across all age groups, particularly among the elderly population. The increasing incidence of chronic conditions such as diabetes, neurological disorders, and mobility impairments further drives the need for catheterisation to manage urinary leakage effectively.

The benign prostate hyperplasia segment is expected to witness the fastest CAGR over the forecast period. This growth can be attributed to the rising prevalence of prostate enlargement among ageing men. Catheters play a crucial role in providing immediate relief from urinary obstruction and its associated symptoms, thereby enhancing patient comfort and quality of life.

End Use Insights

The hospitals segment dominated the urinary catheters market in 2025. This growth can be attributed to the high number of patients requiring catheterisation for acute care, surgical procedures, and perioperative management. Hospitals remain the primary setting for short-term and long-term catheter use, supported by skilled healthcare professionals, strict infection control protocols, and ready access to a wide range of catheter types, including intermittent, indwelling, and coated catheters. 

The long-term care facilities segment is projected to witness the fastest growth rate over the forecast period. This can be attributed to the increasing number of elderly and chronically ill patients requiring continuous urinary management. Residents in nursing homes and assisted living facilities often need long-term or intermittent catheterisation due to age-related conditions, mobility limitations, and chronic urological disorders.

Competitive Landscape

Companies in the urinary catheters market are focusing on developing high-performance catheters that offer additional benefits and improved patient outcomes. These features decrease infection risks while enhancing patient comfort. Businesses are offering customised solutions to cater to specific requirements. Manufacturers are focusing on disposable catheters due to the increasing demand for single-use products that reduce the risk of infections. Companies are broadening their product portfolio beyond urinary catheters to include complementary products. This includes catheter insertion kits, urinary drainage bags, and products for continence care. The growing ageing population and increasing number of surgical procedures and hospitalisations further fuel product demand. In addition, the expanding adoption of home healthcare and the rising preference for minimally invasive and non-invasive urinary management solutions, such as external and intermittent catheters, are accelerating market growth.

List of key players in Urinary Catheters Market

1. Braun Melsungen AG
2. Coloplast A/S
3. Becton, Dickinson and Company
4. Teleflex Incorporated
5. Boston Scientific Corporation
6. Medtronic plc.
7. Hollister Incorporate
8. Cook Medical
9. Cathetrix
10. UroDev Medical
11. Stryker Corporation
12. Consure Medical
13. Urocare Products Inc.
14. Wellspect Healthcare
15. ConvaTec
16. Cardinal Health, Inc.
17. Amsino International Inc.
18. Bactiguard AB

To get more findings about this report Download Market Share

Recent Developments

• In April 2025, Silq Technologies Corporation, a privately owned leader in advanced materials science, secured a national group purchasing agreement and received the Technology Breakthrough Designation from Premier, Inc. The agreement has reportedly enabled Premier’s members to access pre-negotiated pricing and terms for ClearTract catheters.
• In March 2025, Supira Medical announced that the company had raised USD 120 million to complete the clinical development of its temporary heart pump, designed for patients undergoing high-risk cardiac procedures or suffering from shock.